Terms: = Germ cell tumor AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
431 results:
1. B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma.
Shen B; Mei J; Xu R; Cai Y; Wan M; Zhou J; Ding J; Zhu Y
Pathol Res Pract; 2024 Apr; 256():155267. PubMed ID: 38520953
[TBL] [Abstract] [Full Text] [Related]
2. Identification of hypoxic-related lncRNAs prognostic model for revealing clinical prognostic and immune infiltration characteristic of cutaneous melanoma.
Liao C; Yang J; Chen L; Ye Z
Aging (Albany NY); 2024 Feb; 16(4):3734-3749. PubMed ID: 38364250
[TBL] [Abstract] [Full Text] [Related]
3. Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.
Vella V; Ditsiou A; Chalari A; Eravci M; Wooller SK; Gagliano T; Bani C; Kerschbamer E; Karakostas C; Xu B; Zhang Y; Pearl FMG; Lopez G; Peng L; Stebbing J; Klinakis A; Giamas G
Adv Sci (Weinh); 2024 Apr; 11(15):e2306027. PubMed ID: 38353396
[TBL] [Abstract] [Full Text] [Related]
4. Multimodal profiling of chordoma immunity reveals distinct immune contextures.
van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272563
[TBL] [Abstract] [Full Text] [Related]
5. Functional Contribution and clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma.
Galbo PM; Madsen AT; Liu Y; Peng M; Wei Y; Ciesielski MJ; Fenstermaker RA; Graff S; Montagna C; Segall JE; Sidoli S; Zang X; Zheng D
Clin Cancer Res; 2024 Feb; 30(4):865-876. PubMed ID: 38060213
[TBL] [Abstract] [Full Text] [Related]
6. Molecular and clinicopathological implications of PRAME expression in adult glioma.
Le MK; Vuong HG; Dunn IF; Kondo T
PLoS One; 2023; 18(10):e0290542. PubMed ID: 37796789
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Factors for Relapse in Patients With clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
[TBL] [Abstract] [Full Text] [Related]
8. Emilin2 fosters vascular stability by promoting pericyte recruitment.
Fejza A; Camicia L; Carobolante G; Poletto E; Paulitti A; Schinello G; Di Siena E; Cannizzaro R; Iozzo RV; Baldassarre G; Andreuzzi E; Spessotto P; Mongiat M
Matrix Biol; 2023 Sep; 122():18-32. PubMed ID: 37579864
[TBL] [Abstract] [Full Text] [Related]
9. NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma.
Miftah H; Naji O; Ssi SA; Ghouzlani A; Lakhdar A; Badou A
Front Immunol; 2023; 14():1139268. PubMed ID: 37575237
[TBL] [Abstract] [Full Text] [Related]
10. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed cell Death in Lower Grade Glioma.
Ma W; Mei P
World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
[TBL] [Abstract] [Full Text] [Related]
11. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells.
Zhao Z; Ding Y; Tran LJ; Chai G; Lin L
Front Immunol; 2023; 14():1196892. PubMed ID: 37435067
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression.
Jiang X; Zhang Y; Yuan Y; Jin Z; Zhai H; Liu B; Li Y; Zhang C; Chen M; Shi Y; Yan D; Pu J; Chen Y; Yang C
Int J Biol Sci; 2023; 19(6):1681-1697. PubMed ID: 37063420
[TBL] [Abstract] [Full Text] [Related]
13. SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells.
Wen L; Wang XZ; Qiu Y; Zhou YP; Zhang QY; Cheng S; Sun JY; Jiang XJ; Rayner S; Britt WJ; Chen J; Hu F; Li FC; Luo MH; Cheng H
PLoS Pathog; 2023 Apr; 19(4):e1011316. PubMed ID: 37058447
[TBL] [Abstract] [Full Text] [Related]
14. Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue.
Ma S; Zhao H; Wang F; Peng L; Zhang H; Wang Z; Jiang F; Zhang D; Yin M; Li S; Huang J; Liu Z; Tao S
Aging (Albany NY); 2023 Mar; 15(5):1628-1651. PubMed ID: 36917093
[TBL] [Abstract] [Full Text] [Related]
15. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
[TBL] [Abstract] [Full Text] [Related]
16.
Ibáñez-Molero S; van Vliet A; Pozniak J; Hummelink K; Terry AM; Monkhorst K; Sanders J; Hofland I; Landeloos E; Van Herck Y; Bechter O; Kuilman T; Zhong W; Marine JC; Wessels L; Peeper DS
Oncoimmunology; 2022; 11(1):2139074. PubMed ID: 36465485
[TBL] [Abstract] [Full Text] [Related]
17. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
18. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
[TBL] [Abstract] [Full Text] [Related]
19. Mass spectrometry imaging discriminates glioblastoma tumor cell subpopulations and different microvascular formations based on their lipid profiles.
O'Neill KC; Liapis E; Harris BT; Perlin DS; Carter CL
Sci Rep; 2022 Oct; 12(1):17069. PubMed ID: 36224354
[TBL] [Abstract] [Full Text] [Related]
20. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract] [Full Text] [Related]
[Next]